Abstract
A case is presented where the authors carried out a cochlear implantation on a girl whose deafness was induced by cytostatic agents. The normally hearing child was diagnosed with Langerhans cell histiocytosis at the age of 3 years and received polychemotherapy for almost 2 years. By her 5th year, she started to develop a bilateral, progressive sensorineural hearing loss, necessitating a hearing aid in both ears. While her histiocytosis was cured, her hearing ultimately deteriorated to total deafness on the right and profound hearing loss on the left ear. After 3 years, her hearing aids no longer provided adequate hearing for the postlingually deafened girl. At the age of 14, a cochlear implantation was performed on her right ear with excellent results.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bokemeyer C, Berger C C, Kuczyk M A, Schmoll H J (1996) Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 14:2923–2932
Cronin S, Uberti J P, Ayash L J, Raith C, Ratanatharathorn V (2000) Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 26:1247–1249
Formanek M, Czerny C, Gstoettner W, Kornfehl J (1998) Cochlear implantation as a successful rehabilitation for radiation induced deafness. Eur Arch Otorhinolaryngol 255:175–178
Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S (1994) Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 23:72–80
Gray R F, Jones S E M, Court I (2003) Cochlear implantation for progressive hearing loss. Arch Dis Child 88:708–711
Jaffe E S, Harris N L, Stein H, Vardiman J W (2001) Tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, p 280
Lee J S, Lee D S, Oh S H, Kim C S, Kim J, Hwang C H, Koo J, Kang E, Chung J, Lee M C (2003) PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. J Nucl Med 9:1435–1439
Lehnhardt E (1994) Das Cochlearimplantat bei Kindern: Indikation und chirurgische Aspekte. Wien Med Wochenschr 144:8–14
Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H (2000) Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. Klin Padiatr 212:139–144
Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H (2002) Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 39:581–585
Moss P E, Hickman S, Harrison B R (1999) Ototoxicity associated with vinblastine. Ann Pharmacother 33:423–425
Perin G, Dallorso S, Stura M, Moroni C, Rogers D, Dini G, De Bernardi B (1987) High-dose cisplatin and etoposide in advanced malignancies of childhood. Pediatr Hematol Oncol 4:329–336
Ponton CW, Moore JK, Eggermont JJ (1999) Prolonged deafness limits auditory system developmental plasticity: evidence from an evoked potentials study in children with cochlear implants. Scand Audiol [Suppl] 51:13–22
Schweitzer VG (1993) Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 26:759–789
Sweeney C (2001) History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity. Semin Urol Oncol 19:170–179
Torkos A, Jóri J, Tóth F, Szamosközi A, Kiss J G, Czigner J (2002) Successful cochlear implantation in a child after recovery from a head and neck malignancy: a case report. Eur Arch Otorhinolaryngol 259:343–346
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Torkos, A., Czigner, J., Kiss, J.G. et al. Cochlear implantation for treatment-induced ototoxic deafness in Langerhans cell histiocytosis. A case report. Eur Arch Otorhinolaryngol 262, 496–500 (2005). https://doi.org/10.1007/s00405-004-0858-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-004-0858-1